BioLife secures CAR T-cell therapy development deal
BioLife Solutions has secured a deal with an undisclosed global pharmaceutical company to support that firm's regulatory and commercial launch of a new CAR T-cell therapy. Read More
Thermo Fisher opening new biologics site in Switzerland
Thermo Fisher Scientific recently assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland, the company announced. Read More
Brain model shows promise in treating FCMD
A model using stem cell-derived muscle and brain organoids for Fukuyama congenital muscular dystrophy (FCMD)-related brain effects gives new hope for treatment, according to research published in the October 22 issue of iScience. Read More
Latch Bio closes on seed funding, launches CRISPR platform
Latch Bio has closed on a $5 million seed funding round that coincides with the launch of a web-based platform which allows biologists to analyze CRISPR data without writing any code or implementing cloud infrastructure. Read More
Eagle Genomics, Earlham Institute enter into partnership
Eagle Genomics and the Earlham Institute have entered into a partnership that is focused on providing tools required to analyze, explore, and leverage complex microbiome data. Read More
Top-Down Proteomics launches proteoform atlas
The Consortium for Top-Down Proteomics has launched a new effort to build a proteoform atlas to understand disease mechanisms and accelerate diagnostics and drug development. Read More
Dynatrace touts benefits of AI software
Dynatrace is highlighting the integration of its artificial intelligence (AI) software at research and education publisher Wiley. Read More
Gyros launches kit to support gene therapy production
Immunoassay developer Gyros Protein Technologies is introducing a new titer kit called Gyrolab AAV9 to support adeno-associated virus-based cell and gene therapy production. Read More
NDRI receives $12.5M grant to support pediatric research
The National Disease Research Interchange (NDRI) will lead collaborators on a five-year $12.5 million development project to establish a new center as part of the U.S. government's Genotype-Tissue Expression initiative. Read More
Schott Minifab to acquire Applied Microarrays
Microfluidic device developer Schott Minifab will acquire Applied Microarrays, strengthening its ability to offer a single-source manufacturing service. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
